Radnor Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$649K Buy
10,136
+647
+7% +$42.5K 0.09% 206
2026
Q1
$675K Hold
9,489
0.1% 200
2025
Q4
$778K Sell
9,489
-207
-2% -$16.1K 0.12% 181
2025
Q3
$728K Sell
9,696
-237
-2% -$17.7K 0.11% 190
2025
Q2
$736K Buy
9,933
+478
+5% +$33.3K 0.12% 187
2025
Q1
$763K Buy
9,455
+660
+8% +$56.7K 0.13% 178
2024
Q4
$688K Sell
8,795
-43
-0.5% -$3.65K 0.12% 186
2024
Q3
$829K Buy
8,838
+383
+5% +$32.1K 0.12% 186
2024
Q2
$659K Buy
8,455
+569
+7% +$46.4K 0.2% 101
2024
Q1
$717K Sell
7,886
-498
-6% -$41.4K 0.12% 186
2023
Q4
$648K Sell
8,384
-406
-5% -$28.4K 0.12% 183
2023
Q3
$598K Sell
8,790
-522
-6% -$38K 0.12% 186
2023
Q2
$757K Sell
9,312
-124
-1% -$9.89K 0.32% 67
2023
Q1
$774K Buy
+9,436
New +$674K 0.2% 115

Other funds holding GEHC

Radnor Capital Management's GEHC Position: Q2 2026 in Review

Radnor Capital Management increased its GE HealthCare (GEHC) stake by 6.8% in Q2 2026, buying an estimated $42.5K and bringing the position to 10,136 shares worth $649K. The position accounts for 0.09% of the portfolio, ranked #206.

Radnor Capital Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $829K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Radnor Capital Management held 10,136 shares of GE HealthCare worth $649K as of Q2 2026.
  • Radnor Capital Management bought 647 GE HealthCare shares in Q2 2026, an estimated $42.5K.
  • GE HealthCare made up 0.09% of Radnor Capital Management's portfolio in Q2 2026, its #206 holding.
  • Radnor Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Radnor Capital Management's GE HealthCare position peaked at $829K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.